E Canadian LP Pot Stock Sub-Index Continues To Surge

The Canadian Licensed Producer (LP) component of the vertically integrated (i.e. seed-to-sale)  munKNEE Pure-Play Pot Stock Index continues to surge. The sub-index has gone up 97.5% since the beginning of 2021, +22.9% since the beginning of February, and 9.4% just yesterday. This article identifies the winners and losers and the reasons behind there movements.

(For more information on the reason(s) behind the changes outlined below you are urged to click on the stock symbols provided by TalkMarkets, where additional articles are listed. All currency amounts are in U.S. dollars. Go here to convert to another currency.)

LP Pure-Play Pot Stock Index Performance

The criteria for being included in the munKNEE LP Pure-Play Pot Stock Sub-Index is that the constituents are Canadian LPs that consistently trade for a minimum of US$1/share and generate 100% of their revenue directly from the sale of cannabis products.

As we have previously noted, the major surge in the price of LP marijuana stocks is based on the anticipation that, with the Democrats winning the two Senate seats in Georgia giving them a majority in the Senate, favorable Federal marijuana legislation will be passed allowing the Canadian marijuana companies access to the large American market.

The sub-index has gone up 97.5% in the past 5 weeks with all but one of the 10 constituents advancing of which 7 did so in excess of 65%, as follows:

  1. Tilray (TLRY): +218.5% to $26.31/share
  2. Aphria (APHA): +139.9% to $16.60/share
    • Aphria and Tilray have announced plans to merge, creating what will become the largest global cannabis company by revenue
  3. Hexo (HEXO): +115.5% to $7.93/share
    • HEXO and beverage giant Molson Coors have announced that their joint venture, Truss CBD USA, is preparing to launch a new beverage
  4. Canopy (CGC+82.4% to $44.94/share
    • Canopy's Animal Health Division has announced the launch of CBD products for dogs under the brand name SurityPro to support calm behavior, joint health and flexibility, healthy aging, and overall physical and mental well-being.
  5. Organigram (OGI+77.4% to $2.36/share
    • No specific reasons behind surge other than current market sentiment.
  6. Cronos (CRON): +76.5% to $12.25/share
    • No specific reasons behind surge other than current market sentiment.
  7. Aurora (ACB): +65.5% to $13.75/share
    • Aurora has signed a five-year agreement with MedReleaf Australia to become its exclusive supplier of Aurora's MedReleaf, CanniMed and Aurora brands in Australia.
  8. Neptune (NEPT) +28.2% to $2.00/share
    • Neptune has made its first commercial shipment of its in-house developed Cannabis brand Mood Ring Hashish products utilizing its newly implemented and proprietary solvent-less extraction for THC concentrates.
  9. Valens (VLNCF) +3.1% to $1.34/share
    • Valens has acquired LYF Food Technologies Inc., an edibles manufacturer, for CDN$24 .9 million, plus up to an additional CDN$17.5 million payable upon the business achieving certain earn-out EBITDA milestones, to significantly expands its edibles footprint and strengthen its production capabilities for the 2.0 and 3.0 markets.
1 2
View single page >> |

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.